Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks all open today
AI Labs Launches AI-Powered Investment Intelligence Platform to Bring Advanced Technology Stock Analytics to Retail Investors
Shoucheng Holdings (0697.HK) Expands AI Computing Infrastructure Portfolio with Strategic Investment in Shuoguang Precision
IDC Releases Physical AI Map: 51World Emerges as the Only “Three-in-One” Software-Layer Benchmark Covering Models, Simulation, and Data
Visionstate to Pause LIFE Offering and Re-Examine Financing Approach
Helsinn publishes results from a secondary analysis of a Phase 3 trial in patients with…
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
BALTIMORE, Jan. 04, 2023 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused…
NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or…
CBO-212 is a first-in-class inhibitor of CD73 cancer immunotherapy target SAN DIEGO, Jan. 04, 2023…
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
MORRISVILLE, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty…
– Product Revenues, Net Expected in the Range of $565.0 Million to $580.0 Million –…
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
SALT LAKE CITY, Jan. 04, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
GERMANTOWN, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — TeraImmune, Inc., a biotechnology company focused on…
WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage…
POTOMAC, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc….
– The Expanded Access Program (EAP) allows physicians to request access to TransCon PTH, the…
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient…
SYDNEY, AUSTRALIA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Dr. Susana Banerjee (The Royal Marsden NHS Foundation Trust, UK), will be the ENGOT and…
Nes-Ziona, Israel, Jan. 04, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…